Cargando…
Targeting epigenetic modifiers to reprogramme macrophages in non-resolving inflammation-driven atherosclerosis
Epigenomic and epigenetic research has been providing several new insights into a variety of diseases caused by non-resolving inflammation, including cardiovascular diseases. Atherosclerosis (AS) has long been recognized as a chronic inflammatory disease of the arterial walls, characterized by local...
Autores principales: | Jin, Fengyan, Li, Jian, Guo, Jianfeng, Doeppner, Thorsten R, Hermann, Dirk M, Yao, Gang, Dai, Yun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241575/ https://www.ncbi.nlm.nih.gov/pubmed/35919269 http://dx.doi.org/10.1093/ehjopen/oeab022 |
Ejemplares similares
-
Diverse Epigenetic Regulations of Macrophages in Atherosclerosis
por: Yang, Hongmei, et al.
Publicado: (2022) -
Epigenetics: Reprogrammable interface of the genome and environments
por: Sasaki, Takashi
Publicado: (2013) -
Identification of the histone lysine demethylase KDM4A/JMJD2A as a novel epigenetic target in M1 macrophage polarization induced by oxidized LDL
por: Wang, Xue, et al.
Publicado: (2017) -
Electrically driven reprogrammable phase-change metasurface reaching 80% efficiency
por: Abdollahramezani, Sajjad, et al.
Publicado: (2022) -
Checkpoint inhibitor blockade and epigenetic reprogrammability in CD8(+) T-cell activation and exhaustion
por: Belizário, José, et al.
Publicado: (2020)